Mindera Health

Mindera Health technology generates clinically validated data to lower healthcare costs and improve patient outcomes.

[Mindera Health @MinderaHealth]

Our Goal is Clear... To Learn More About Mind.Px™ Visit https://t.co/lYMgf4MFbG

#psoriasis #Pso #precisionmedicine

[Mindera Health @MinderaHealth]

Study demonstrated utilization of Mind.Px led to a change in physician biologic prescribing behavior. Ninety-three percent of healthcare providers utilized Mind.Px test results in their biologic selection.
Read More Here: https://t.co/myW3KiBINO

#MindPx #PrecisionMedicine #Biologics #PsoriasisTreatments #MATCH

[Mindera Health @MinderaHealth]

Today, Mindera Health announces positive clinical utility findings from the MATCH study published in the peer reviewed journal Dermatology and Therapy.

The study met the primary endpoint, demonstrating utilization of Mind.Px led to a significant change in physician biologic prescribing behavior and improved patient outcomes.

Read More Here: https://t.co/uil2pgenDG

[Mindera Health @MinderaHealth]

Today we announce our participation in MultiPlan national PPO networks. Effective immediately, health plan members who access MultiPlan’s PHCS and MultiPlan Networks have access to #MindPx

Read More: https://t.co/pUuOgd2ilQ

[Mindera Health @MinderaHealth]

Today: Mindera Health™ Announces Issuance of Additional International Patent Coverage for Dermal Biomarker Patch Platform

Read More: https://t.co/qSapbJRPX8

[Mindera Health @MinderaHealth]

Announcment: Mindera Health Partners with National Psoriasis Foundation to Advance Precision Medicine in Psoriasis Treatment

Read More: https://t.co/PAFQNpTzJE

[Mindera Health @MinderaHealth]

Mindera Health™ Announces Issuance of Additional International Patent Coverage for Dermal Biomarker Patch Platform.

Australian patent number 2020239750 covers devices that can extract dermal biomarkers in situ.

[Mindera Health @MinderaHealth]

Mindera Health™ Announces Contract With General Services Administration®

General Services Administration (GSA) has awarded a 5-year contract to Mindera Health, enabling access to the Mind.Px™ test for patients with plaque psoriasis considering biologic therapy.

[Mindera Health @MinderaHealth]

This commercial agreement will make Mindera’s psoriasis biologic prediction test, Mind.Px™, available to the more than 15 million lives served by Clients and Payers of MediNcrease.

[Mindera Health @MinderaHealth]

BREAKING NEWS!

Mindera Health™ today announces the signing of a network provider contract with MediNcrease Health Plans, a national provider network and provider advocacy firm.

Read more: https://t.co/fEyvzsOFAb

[Mindera Health @MinderaHealth]

Join us in breaking the stigma and misconceptions surrounding Psoriasis. Take a few minutes to watch this educational video debunking 6 myths about Psoriasis and share this post with your network.

https://t.co/G3E3eZElwl

#PsoriasisAwareness #PsoriasisCommunity #PsoriasisWarrior

[Mindera Health @MinderaHealth]

With Mindera's Mind.Px test, boasting a >91% positive predictive value (PPV), you can confidently choose the most suitable biologic drug class for your patient, whether it’s an IL-23, IL-17 or an anti-TNFa.

Learn more: https://t.co/fzXe43fYdK

#psoriasis #dermatology

[Mindera Health @MinderaHealth]

Mind.Px dermal biomarker patch, boasting an impressive >91% Positive Predictive Value (PPV), gives you the confidence to determine the best biologic drug class for your patient, the first time.

[Mindera Health @MinderaHealth]

We all want to predict the future, particularly when it concerns the well-being of our patients. Choosing the right Psoriasis biologic drug class for your patient can be as uncertain as crystal ball gazing. That's where Mind.Px comes in.

Learn More: https://t.co/XumpOWQBBI

[Mindera Health @MinderaHealth]

August is Psoriasis Awareness Month!

Psoriasis affects millions worldwide, and we need to spread awareness about this chronic skin condition. Join us in breaking the stigma and misconceptions surrounding Psoriasis.

Learn more here: https://t.co/KvLnkqWBjx

#PsoriasisAwareness

[Mindera Health @MinderaHealth]

On your way to Vegas? Stop by booth T29 to learn about Mind.px at Stranger Dx - Derm2023!

#dermalintelligence #personalizedmedicine #derm2023

[Mindera Health @MinderaHealth]

Don't leave it to chance. Statistics show that determining the right psoriasis biologic drug class for your patient is as uncertain as calling a coin flip. Increase your certainty with Mindera's dermal biomarker patch -- with >91% PPV -- Mind.Px.

#psoriasis #biologics #derm

[Mindera Health @MinderaHealth]

At Mindera Health, we LOVE the summer! With the nice weather and long days, we know you'll have some fun in the sun. If you suffer from psoriasis, the suggests using skincare products containing aloe, jojoba, zinc, or capsaicin to hydrate and lock in moisture.

#psoriasis

[Mindera Health @MinderaHealth]

We're excited to be at #SCALE2023 in legendary Music City, Nashville, TN. We're even more excited to be a Gold Sponsor! Stop by Mindera Health's booth #205 to learn about the latest precision medicine innovation for #Psoriasis. https://t.co/uCnlQgvTFP @scalemusiccity

[Mindera Health @MinderaHealth]

Industry veteran, Ron Rocca, will succeed George Mahaffey as President and CEO of Mindera Health. Mr. Rocca brings over two decades of biotech and diagnostics industry experience. His prior role was President and CEO of Exagen Inc.

Read more: https://t.co/JLOcjVAqYi